BTIG Research raised the price target for the Signify Health Inc. (NYSE:SGFY) stock to “a Buy”. The rating was released on August 31, 2022, according to finviz. The research report from Robert W. Baird has upgraded the stock from Neutral to Outperform, with a price target set at $16. The stock was initiated by Guggenheim, who disclosed in a research note on March 30, 2022, to Buy and set the price objective to $36. In their research brief published March 09, 2022, UBS analysts upgraded the Signify Health Inc. stock from Neutral to Buy with a price target of $21.
The latest trade, Performances and Moving Averages give us the following Picture
The share price of Signify Health Inc. (NYSE:SGFY) dipped -0.17% to close Tuesday’s market session at $28.67, lower as compared to yesterday’s close. The stock price fluctuated between $28.58 and $28.85 throughout the trading session with the volume trading being 1379369 shares, which represented a significant variation when compared to the three months average volume of 1.53 million shares. The firm’s stock price fluctuated -0.66% within the last five trades and 0.07% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price increased 74.39% in the last 6 months and -2.02% was subtracted to its value over the previous 3 months. SGFY stock is trading at a margin of -0.04%, 0.16% and 27.05% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.
As of the close of trading, SGFY deals in the Healthcare domain. The stock is trading -4.05 percent below its 52-week high and 167.94 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is 100.48. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.
What Does Signify Health Inc.’s Profitability and Valuation Ratios Tell Us About the Stock?
With regard to the profitability of the company, the operating margin is currently at -74.00 percent and the profit margin is -66.00 percent, and the company has reported a gross margin of 41.80 percent. The profit margin, also known as the revenue ratio or gross profit ratio, is an efficiency figure used to estimate the business’s profitability by comparing net income and sales. The higher the number, the more profits are generated for the company and vice versa.
The stock’s market cap achieved a total value of $6.78 billion as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. The price-to-earnings ratio is a method of assessing corporate values by comparing them to their per-share profit. Forward P/E stands at 84.32. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The stock has achieved an effective Price-to-Sales Ratio of 8.65 that mirrors the cost to be found for sales by the market. The firm managed a Price-to-Book ratio of 10.28, which equates the market value of a stock with its book value.
Is Insider Trading a Real Thing?
Senneff Steve, the Pres. Chief Fin. & Admin. Off. at Signify Health Inc. (SGFY) has bought 2,500 shares of firm on May 09 at a price of $11.75 against the total amount of $29372.0. In another inside trade, Armbrester Bradford Kyle, Chief Executive Officer of Signify Health Inc. (NYSE:SGFY) bought 8,320 shares of the firm on May 09 for a total worth of $97891.0 at a price of $11.77. An inside trade which took place on May 06, Pres. Chief Fin. & Admin. Off. of Signify Health Inc. Senneff Steve bought 10,000 shares of firm against total price of $0.13 million at the cost of $12.55 per share.